Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating GV1001 for Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• GV1001

Snippet

Sponsor: GemVax & Kael | Conditions: Alzheimer Disease | Phase 2 | Status: COMPLETED